- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MP-23-0066075

Next Era Pharmaceuticals Private Limited
About Next Era Pharmaceuticals Private Limited
Data last updated:
Next Era Pharmaceuticals Private Limited is a private limited company based in Indore, Madhya Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 17 December 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U52395MP2021PTC058846. Its GSTIN is 23AAHCN9835C1ZH (Madhya Pradesh). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Pawan Arora and Dharmik Arora.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O Pawan Arora 7 Rajgarh Kothi Shop G – 3 Aushi Apartment, Indore, Madhya Pradesh, India – 452001.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.03 Cr, a growth of 10% compared to the previous year. For the same year it recorded a net profit of ₹2.37 Lakh (net margin 2.3%) and EBITDA of ₹7.95 Lakh (EBITDA margin 7.7%).
As per MCA filings, the company has open charges of ₹61.67 Lakh on record.
Next Era Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MP-23-0066075).
Company details
Recognitions & Rankings of Next Era Pharmaceuticals
Contact details
Next Era Pharmaceuticals Private Limited's registered office is in Indore, Madhya Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressC/O Pawan Arora 7 Rajgarh Kothi Shop G – 3 Aushi Apartment, Indore, Madhya Pradesh, India – 452001
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Next Era Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Next Era Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Next Era Pharmaceuticals Private Limited, buy the company report.
Financials of Next Era Pharmaceuticals Private Limited
FY 2025 filings availableNext Era Pharmaceuticals Private Limited reported revenue of ₹1.03 Cr (up 10% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 10% in the latest year. EBITDA rose 192% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹7.95 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹2.37 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 7.7% | |||
| Net Profit Margin | 2.3% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Next Era Pharmaceuticals Private Limited, buy the company report.
Board of directors of Next Era Pharmaceuticals Private Limited
Next Era Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pawan Arora | Director | 17 Dec 2021 | 4 Years 10 Months | Current |
| Dharmik Arora | Director | 17 Dec 2021 | 4 Years 10 Months | Current |
Peer comparison
Next Era Pharmaceuticals Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| One Pharma Drugs & Pharmaceuticals Private Limited | ₹1.04 Cr (FY 2024) | 8.0% | New Delhi, Delhi, India | |||
| Biomarilyn Pharmaceuticals Private Limited | ₹1.04 Cr (FY 2024) | 14.0% | Bangalore, Karnataka, India | |||
| Vags Pharmaceuticals Private Limited | ₹1.03 Cr (FY 2020) | 418.0% | Meerut, Uttar Pradesh, India | |||
| Next Era Pharmaceuticals Private Limitedthis company | ₹1.03 Cr (FY 2025) | ₹2.37 Lakh | 2.3% | 10.0% | Indore, Madhya Pradesh, India | |
| Wiliance Pharmaceuticals Private Limited | ₹1.03 Cr (FY 2025) | -6.0% | Bhopal, Madhya Pradesh, India | |||
| Virtus Pharmaceuticals Private Limited | ₹1.02 Cr (FY 2023) | 6.0% | Hyderabad, Telangana, India | |||
| Velliq Pharmaceuticals Private Limited | ₹1.02 Cr (FY 2025) | 20.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Next Era Pharmaceuticals Private Limited, buy the company report.
Auditor
Next Era Pharmaceuticals Private Limited is audited by ABHAY KUMAR JAIN & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ABHAY KUMAR JAIN & CO. | FY 2023 | 006386C |
Shareholding
The shareholding of Next Era Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Next Era Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 27 Mar 2025 | 101106197 | Hdfc Bank Limited | ₹21.67 Lakh | Open | |
| 29 Jul 2024 | 100968424 | Others | ₹40 Lakh | Open |
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Next Era Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Next Era Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Next Era Pharmaceuticals Private Limited has 1 active EPFO establishment as of Mar 29, 2024.
GST
Next Era Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AAHCN9835C1ZH | Madhya Pradesh | Active | 04 Jul 2022 |
To see the full GST registrations and return filing status of Next Era Pharmaceuticals Private Limited, buy the company report.
Recent activity
Next Era Pharmaceuticals Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Dharmik Arora was appointed as Director on 17 Dec 2021.
Frequently asked questions
Next Era Pharmaceuticals is an active private limited company based in Indore, Madhya Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 17 December 2021 (5+ years old) and is registered under CIN U52395MP2021PTC058846.
Next Era Pharmaceuticals has 2 current directors:
- Pawan Arora - Director
- Dharmik Arora - Director
The latest financial statements of Next Era Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Next Era Pharmaceuticals is 23AAHCN9835C1ZH, registered in Madhya Pradesh. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Next Era Pharmaceuticals is U52395MP2021PTC058846. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Next Era Pharmaceuticals was incorporated on 17 December 2021, making it 5+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Next Era Pharmaceuticals by revenue are One Pharma Drugs & Pharmaceuticals Private Limited, Biomarilyn Pharmaceuticals Private Limited, Vags Pharmaceuticals Private Limited, Wiliance Pharmaceuticals Private Limited, Virtus Pharmaceuticals Private Limited and 1 more, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Dharmik Arora was appointed as Director on 17 Dec 2021. Pawan Arora was appointed as Director on 17 Dec 2021.
Yes, Next Era Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MP-23-0066075).
The registered office of Next Era Pharmaceuticals is at CO Pawan Arora 7 Rajgarh Kothi Shop G – 3 Aushi Apartment, Indore, Madhya Pradesh, India – 452001.
Next Era Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

